XML 63 R23.htm IDEA: XBRL DOCUMENT v3.24.1
Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Schedule Of Crypto Assets Earned From BitCoins

Crypto assets earned from staking to BTCS validator nodes                  

 

   FY 2022   FY 2022   FY 2023   FY 2023 
Asset  Token Rewards   Revenue ($USD)   Token Rewards   Revenue ($USD) 
Ethereum (ETH)   390   $768,992    358   $639,357 
Cosmos (Atom)   15,200   $214,217    43,268   $408,964 
Kava (KAVA)   49,690   $114,603    53,435   $43,642 
Kusama (KSM)   824   $73,138    820   $21,981 
Mina (MINA)   4,320   $2,594    15,840   $10,959 
Evmos (EVMOS)   -   $-    89,591   $10,807 
Akash (AKT)   6,376   $1,459    11,666   $9,808 
Avalanche (Avax)   1,051   $30,791    664   $9,117 
NEAR Protocol (NEAR)   970   $1,512    5,494   $8,836 
Oasis Network (ROSE)   9,758   $533    98,001   $5,802 
Tezos (XTZ)   3,620   $7,048    2,413   $2,326 
Terra (Luna)   61   $5,401    -   $- 
Algorand (Algo)   98   $115    -   $- 
Total earned from staking to BTCS validator nodes   -   $1,220,403        $1,171,599 
Schedule of Crypto Assets Earned From Third Party

Crypto assets earned from staking to third-party validator nodes                  

 

   FY 2022   FY 2022   FY 2023   FY 2023 
Asset  Token Rewards   Revenue ($USD)   Token Rewards   Revenue ($USD) 
Axie Infinity (AXS)   17,392   $385,101    18,522   $127,691 
Polygon (Matic)   31,395   $27,826    24,878   $20,613 
Solana (SOL)   407   $20,428    474   $11,592 
Polkadot (DOT)   2,989   $35,658    1,371   $7,358 
Cardano (ADA)   5,102   $3,038    2,394   $775 
Total earned from staking to third-party validator nodes       $472,051        $168,029 
Total       $1,692,454        $1,339,628 
Schedule of Earnings Per Share Anti-diluted

The following financial instruments were not included in the diluted loss per share calculation as of December 31, 2023 and 2022 because their effect was anti-dilutive:

 

   2023   2022 
   As of December 31, 
   2023   2022 
Warrants to purchase common stock   712,500    912,500 
Options   1,200,000    1,150,000 
Non-vested restricted stock awards units   1,606,373    1,590,553 
Total   3,518,873    3,653,053